Literature DB >> 34917248

Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2021        PMID： 34917248      PMCID： PMC8667067          DOI： 10.1021/acsmedchemlett.1c00619

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  Inducible tyrosine kinase inhibitors: a review of the patent literature (2010 - 2013).

Authors:  Peter Norman
Journal:  Expert Opin Ther Pat       Date:  2014-07-03       Impact factor: 6.674

Review 2.  Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis.

Authors:  Kristina S Lechner; Markus F Neurath; Benno Weigmann
Journal:  J Mol Med (Berl)       Date:  2020-08-18       Impact factor: 4.599

Review 3.  Targeting ITK signaling for T cell-mediated diseases.

Authors:  Samuel Weeks; Rebecca Harris; Mobin Karimi
Journal:  iScience       Date:  2021-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.